EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Mefloquine enhances the efficacy of anti-PD-1 immunotherapy via IFN-γ-STAT1-IRF1-LPCAT3-induced ferroptosis in tumors

Qian Tao, Nian Liu, Jie Wu, Jing Chen, Xiang Chen, Cong Peng iD

Journal for ImmunoTherapy of Cancer · 2024-03 · 12 (3) · e008554

DOI: 10.1136/jitc-2023-008554 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, online erschienen am 11.03.2024. Verfasst von Qian Tao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, China. Hauptthemen laut MEDLINE: Melanoma, Ferroptosis, Lung Neoplasms. Die Arbeit wurde bisher 68-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: the science and technology innovation Program of Hunan Province, 111 Project, Natural Science Foundation of Hunan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ferroptosis plays an important role in enhancing the efficacy of anti-programmed cell death 1 (PD-1) immunotherapy; however, the molecular mechanisms by which tumor ferroptosis sensitizes melanoma and lung cancer to anti-PD-1 immunotherapy have not been elucidated.

Methods

Cytotoxicity assays, colony formation assays, flow cytometry and animal experiments were used to evaluate the effects of mefloquine (Mef) on survival and ferroptosis in melanoma and lung cancer. RNA sequencing, Real-time quantitative PCR (qRT-PCR), western blotting, chromatin immunoprecipitation-qPCR and flow cytometry were used to determine the molecular mechanisms by which Mef regulates lysophosphatidylcholine acyltransferase 3 (LPCAT3). The relationship between LPCAT3 and the efficacy of anti-PD-1 immunotherapy was verified via a clinical database and single-cell RNA sequencing (ScRNA-Seq).

Results

In this study, we discovered that Mef induces ferroptosis. Furthermore, treatment with Mef in combination with T-cell-derived interferon-γ (IFN-γ) enhanced tumor ferroptosis and sensitized melanoma and lung cancer cells to anti-PD-1 immunotherapy. Mechanistically, Mef upregulated the expression of LPCAT3, a key gene involved in lipid peroxidation, by activating IFN-γ-induced STAT1-IRF1 signaling, and knocking down LPCAT3 impaired the induction of ferroptosis by Mef+IFN-γ. Clinically, analysis of the transcriptome and single-cell sequencing results in patients with melanoma showed that LPCAT3 expression was significantly lower in patients with melanoma than in control individuals, and LPCAT3 expression was positively correlated with the efficacy of anti-PD-1 immunotherapy.

Conclusions

In conclusion, our study demonstrated a novel mechanism by which LPCAT3 is regulated, and demonstrated that Mef is a highly promising new target that can be utilized to enhance the efficacy of anti-PD-1 immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaFerroptosisLung NeoplasmsAnimalsHumansMefloquineInterferon-gammaCell Line, TumorImmunotherapySTAT1 Transcription FactorInterferon Regulatory Factor-11-Acylglycerophosphocholine O-Acyltransferase

Stichwörter der Autor:innen

Immune Checkpoint InhibitorLung CancerMelanoma

Substanzen

MefloquineInterferon-gammaSTAT1 protein, humanSTAT1 Transcription FactorIRF1 protein, humanInterferon Regulatory Factor-1LPCAT3 protein, human1-Acylglycerophosphocholine O-Acyltransferase

Autor:innen und Institutionen

  • Department of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Furong Laboratory, Central South University, Changsha, Hunan, China.
  • Hunan Key Laboratory of Skin Cancer and Psoriasis, Human Engineering Research Center of Skin Health and Disease, Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Department of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, China pengcongxy@csu.edu.cn chenxiangck@126.com.

ORCID-Profile: Cong Peng

Förderung

  • the science and technology innovation Program of Hunan Province
  • 111 Project
  • Natural Science Foundation of Hunan Province
  • National Natural Science Foundation of China, Grant

Zitieren

APA

Tao, Q., Liu, N., Wu, J., Chen, J., Chen, X., & Peng, C. (2024). Mefloquine enhances the efficacy of anti-PD-1 immunotherapy via IFN-γ-STAT1-IRF1-LPCAT3-induced ferroptosis in tumors. Journal for ImmunoTherapy of Cancer, 12(3), e008554. https://doi.org/10.1136/jitc-2023-008554

Vancouver

Tao Q, Liu N, Wu J, Chen J, Chen X, Peng C. Mefloquine enhances the efficacy of anti-PD-1 immunotherapy via IFN-γ-STAT1-IRF1-LPCAT3-induced ferroptosis in tumors. Journal for ImmunoTherapy of Cancer. 2024;12(3):e008554. doi:10.1136/jitc-2023-008554

BibTeX
@article{Tao2024,
  author = {Tao, Qian and Liu, Nian and Wu, Jie and Chen, Jing and Chen, Xiang and Peng, Cong},
  title = {Mefloquine enhances the efficacy of anti-PD-1 immunotherapy via IFN-γ-STAT1-IRF1-LPCAT3-induced ferroptosis in tumors},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2024},
  volume = {12},
  number = {3},
  pages = {e008554},
  doi = {10.1136/jitc-2023-008554}
}
Kostenlos starten →